Received Jan 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
ALLERGIES: PNEUMOVAX; This Spontaneous report was received from Consumer or other non health professional and referred to a 67 -year-old Female patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication. On an unknown date, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) Solution (PNEUMOVAX) for prophylaxis (dose, route of administration, anatomical location, lot number and expiration date were not reported). On an unknown date, the patient experienced allergy to Pneumococcal Vaccine, Polyvalent (23-valent) Solution (PNEUMOVAX) (Allergy to vaccine). The outcome of allergy to vaccine was not provided. Causality assessment between the event and vaccination with Pneumococcal Vaccine, Polyvalent (23-valent) Solution (PNEUMOVAX) was assessed as related. Additional information is not expected.; Sender's Comments: Priority : 4 , Is case serious : No , Index user : [withheld]@merck.com , Index date : 2025-12-29 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 202500208720 , Central date : 2025-12-29 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :